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Abstract— The number of biomedical image analysis 
challenges organized per year is steadily increasing. These 
international competitions have the purpose of benchmarking 
algorithms on common data sets, typically to identify the best 
method for a given problem. Recent research, however, revealed 
that common practice related to challenge reporting does not 
allow for adequate interpretation and reproducibility of results. 
To address the discrepancy between the impact of challenges 
and the quality (control), the Biomedical I mage Analysis 
ChallengeS (BIAS) initiative developed a set of 
recommendations for the reporting of challenges. The BIAS 
statement aims to improve the transparency of the reporting of 
a biomedical image analysis challenge regardless of field of 
application, image modality or task category assessed. This 
article describes how the BIAS statement was developed and 
presents a checklist which authors of biomedical image analysis 
challenges are encouraged to include in their submission when 
giving a paper on a challenge into review. The purpose of the 
checklist is to standardize and facilitate the review process and 
raise interpretability and reproducibility of challenge results by 
making relevant information explicit. 
Keywords—Biomedical challenges, Good scientific practice, 
Biomedical image analysis, Guideline 
I. INTRODUCTION  
The importance of data science techniques in almost all 
fields of biomedicine is increasing at an enormous pace [1,2]. 
This holds particularly true for the field of biomedical image 
analysis, which plays a crucial role in many areas including 
tumor detection, classification, staging and progression 
modeling [3,4,5] as well as automated analysis of cancer cell 
images acquired using microscopy [6,7,8]. 
While clinical trials are the state of the art methods to 
assess the effect of new medication in a comparative manner 
[9], benchmarking in the field of image analysis is performed 
by so-called challenges. Challenges are international 
competitions, typically hosted by individual researchers, 
institutes, or societies, that aim to assess the performance of 
multiple algorithms on identical data sets and encourage 
benchmarking [10]. They are often published in prestigious 
journals [11,12,13,14,15,16], are associated with significant 
amounts of prize money (up to €1 million on platforms like 
Kaggle [17]) and receive a huge amount of attention, indicated 
by the number of downloads, citations and views. A recent 
comprehensive analysis of biomedical image analysis 
challenges, however, revealed a huge discrepancy between the 
impact of a challenge and the quality (control) of the design 
and reporting standard. It was shown that (1) “common 
practice related to challenge reporting is poor and does not 
allow for adequate interpretation and reproducibility of 
results”, (2) “challenge design is very heterogeneous and lacks 
common standards, although these are requested by the 
community” and (3) “challenge rankings are sensitive to a 
range of challenge design parameters, such as the metric 
variant applied, the type of test case aggregation performed 
and the observer annotating the data” [18]. The authors 
conclude that “journal editors and reviewers should provide 
motivation to raise challenge quality by establishing a 
rigorous review process.” 
The Enhancing the QUAlity and Transparency Of health 
Research (EQUATOR) network is a global initiative with the 
aim of improving the quality of research publications and 
research itself. A key mission in this context is to achieve 
accurate, complete and transparent reporting of health 
research studies to support reproducibility and usefulness. A 
core activity of the network is to assist in the development, 
dissemination and implementation of robust reporting 
guidelines, where a guideline is defined as “a checklist, flow 
diagram or structured text to guide authors in reporting a 
specific type of research'” [19]. Between 2006 and 2019, more 
than 400 reporting guidelines have been published under the 
umbrella of the equator network. A well-known guideline is 
the CONSORT statement [20,21] developed for reporting of 
randomized controlled trials. Prominent journals, such as 
Lancet, Jama or the British Medical Journal require the 
CONSORT checklist to be submitted along with the actual 
paper when reporting results of a randomized controlled trial. 
Inspired by this success story, the Biomedical Image 
Analysis ChallengeS (BIAS) initiative was founded by the 
challenge working group of the Medical Image Computing 
and Computer Assisted Intervention (MICCAI) Society board 
with the goal of bringing biomedical image analysis 
challenges to the next level of quality. 
As a first step towards better scientific practice, this paper 
of the initiative presents a guideline to standardize and 
facilitate the writing and reviewing process of biomedical 
image analysis challenges and help readers of challenges 
interpret and reproduce results by making relevant 
information explicit.   
Please note that we do not want to put unnecessary 
restrictions on researchers. For this reason, the template for 
challenge papers as proposed in the following sections merely 
serves as guidance, and authors are free to arrange the relevant 
information in any way they want. What we regard as 
important is for the information in the paper to be complete, 
such that transparency and reproducibility can be guaranteed. 
For this reason, we encourage authors of challenge papers to 
submit the checklist presented in this manuscript (Appendix A) 
along with their paper such that reviewers can easily verify 
whether the information on challenge design and results is 
comprehensive. If information is missing (represented by 
“n/a” in the column reported on page No of the checklist) it is 
up to the reviewers to request adding it. 
Section 2 introduces the terminology used to describe 
challenges and describes the process applied to generate this 
guideline document. Section 3 gives recommendations on 
how to report the design and results of a biomedical image 
analysis challenge. The paper then closes with a brief 
discussion in section 4. 
II. METHODS 
In this paper, we define a biomedical image analysis 
challenge as an open competition on a specific scientific 
problem in the field of biomedical image analysis [18]. A 
challenge may encompass multiple competitions related to 
multiple tasks, whose participating teams may differ and for 
which separate rankings/leaderboards/results are generated. 
For example, a challenge may target the problem of 
anatomical structure segmentation in computed tomography 
(CT) images, where one task may refer to the segmentation 
of the liver and a second task may refer to the segmentation 
of the kidney. We use the term case to refer to a data set for 
which a participating algorithm(s) produce one result (e.g. a 
segmentation or classification). Each case must include at 
least one image of a biomedical imaging modality. 
 
Metrics are used to compute the performance of an 
algorithm for a given case and should reflect the property(ies) 
of the algorithms to be optimized. Note that we do not use the 
term metric in the strict mathematical sense. Metrics are 
usually computed by comparing the results of the 
participating team with a reference annotation. We prefer the 
term reference (alternatively: gold standard) compared to 
ground truth because reference annotations are typically only 
approximations of the (forever unknown) truth [22]. 
 
Typically, a challenge has a training phase of several 
weeks or months, at the beginning of which the challenge 
organizers release training cases with corresponding 
reference annotations. These annotations help the 
participating teams develop their method (e.g. by training a 
machine learning algorithm). Alternatively, the training data 
are not directly released but participating teams may submit 
their algorithms to the challenge platform (using Docker 
containers, for example [23]). Note that the official training 
phase may be preceded by a dry run phase. During this phase, 
the challenge organizers may themselves work with the data 
to determine the level of difficulty of the task(s), for example. 
In the test phase, participating teams either upload their 
algorithms, or they get access to the test cases without the 
reference annotations and submit the results of their 
algorithms on the test cases to the challenge organizers. This 
procedure may be replaced or complemented by an on-site 
challenge event in which participating teams receive a set of 
test cases and are asked to produce the corresponding results 
on-site (typically on the same day). 
 
For many challenges a ranking of the participating teams 
is produced based on the metric values computed for the test 
cases. Note that some challenges additionally include a 
validation phase between training and test phase, in which 
initial rankings (so-called leaderboards) are generated to 
show participating teams how well their methods generalize. 
Insights in this step may be used for final parameter tuning.  
A glossary of some of the terms used in this paper is provided 
in Appendix B. 
 
The procedure to generate this guideline document was 
heavily based on a previous study related to the critical 
analysis of common practice in challenge organization [18] 
and is summarized in the following paragraphs: 
 
Challenge capture To analyze the state of the art in 
the field, the publicly available data on biomedical image 
analysis challenges was acquired. To capture a challenge in a 
structured manner, a list of 53 challenge parameters was 
compiled by a group of 49 scientists from 30 institutions 
worldwide. These parameters include information on the 
challenge organization and participation conditions, the 
mission of the challenge, the challenge data sets (e.g. number 
of training/test cases, information on imaging protocols), the  
assessment method (e.g. metrics and ranking scheme) and 
challenge outcome (e.g. rankings). Analysis of websites 
hosting and presenting challenges, such as grand-
challenge.org, dreamchallenges.org and kaggle.com yielded 
a list of 150 biomedical image analysis challenges with 549 
tasks performed in a time span of 12 years [18]. Between 
2014 and 2016, most challenges were organized in the scope 
of international conferences, primarily the MICCAI 
conference (48%) and the International Symposium on 
Biomedical Imaging (ISBI) (24%). More recently, an 
increasing number of challenges are hosted on platforms like 
Kaggle [17], Synapse (for the DREAM challenges [24,25]) 
and crowdAI [26] (for the ImageCLEF challenges). Details 
on the challenge characteristics (e.g. imaging modalities 
applied, algorithm categories investigated, number of 
training/test cases) can be found in [18]. 
 
Analysis of challenge reporting It was found 
that reports on biomedical challenges covered only a median 
of 62% of the 53 challenge parameters identified as relevant 
by the international consortium. The list of parameters often 
not reported include some that are crucial for interpretation 
of results such as information on how metrics are aggregated 
to obtain a ranking, whether training data provided by 
challenge organizers may have been supplemented by other 
data, and how the reference annotation was performed and by 
whom. It was further found that challenge design is highly 
heterogeneous, as detailed in [18]. 
 
Prospective structured challenge capture To address 
some of the issues, a key conclusion of [18] was to publish 
the complete challenge design before the challenge by 
instantiating the list of parameters proposed. To test the 
applicability of this recommendation, the MICCAI board 
challenge working group initiated using the parameter list for 
structured submission of challenge proposals for the MICCAI 
conferences 2018 and 2019. The submission system required 
a potential MICCAI 2018/2019 challenge organizer to 
instantiate at least 90% of a reduced set of 40 parameters (cf. 
Tab. 1 in [1]) that were regarded as essential for judging the 
quality of a challenge design proposal. The median 
percentage of parameters instantiated was 100% (min: 94%) 
(16/25 submitted challenges in 2018/2019). 
 
Finalization of checklist Based on the pros-
pective challenge capture, the parameter list was revised by 
the MICCAI board challenge working group to improve 
clarity. A questionnaire was then sent to all co-authors to 
acquire final feedback on the parameters. Each author had to 
independently assess every single parameter (n = 48) of the 
list by answering the following questions: 
1. I agree with the name (yes/sort of/no). 
2. I agree with the explanation (yes/sort of/no). 
3. If you do not agree with the name or the 
explanation, please provide constructive 
feedback. 
4. Please rate the importance of the checklist item. 
If you think that it is absolutely essential for 
challenge result interpretation and/or challenge 
participation put absolutely essential. Otherwise 
choose between should be included and may be 
omitted. 
5. Please indicate whether the checklist item(s) is 
(are) essential for challenge review (yes/no). 
To identify missing information, participants were also 
asked to add further relevant checklist items that were not 
covered and to add any other issue important to compile the 
checklist. The MICCAI board challenge working group then 
developed a proposal to address all the comments and points 
of criticism raised in the poll. In a final conference call with 
the co-authors of this paper, remaining conflicts were 
resolved, and the checklist was finalized, resulting in a list of 
42 main parameters and 79 sub-parameters. 
 
The following sections describe the authors' 
recommendations on how to report the design and outcome 
of individual tasks of a biomedical image analysis challenge 
based on this parameter list. The corresponding reviewer 
checklist is provided in Appendix A. 
III. GUIDELINE FOR CHALLENGE REPORTING 
Following standard scientific writing guidelines, we propose 
dividing a challenge paper into the sections Introduction, 
Methods, Results and Discussion, where the Methods section 
corresponds to the challenge design and the Results section 
corresponds to the challenge outcome. These sections are 
preceded by a concise title and abstract as well as a list of 
representative keywords to summarize the challenge mission 
and outcome. The following sections give basic 
recommendations on how to structure and write the 
individual sections. Appendix A serves as a structured 
summary of this section. 
 
A. Title, Abstract and Keywords 
The title should convey the essential information on the 
challenge mission. In particular, it should identify the paper as 
biomedical image analysis challenge and indicate the image 
modality(ies) applied as well as the task category (e.g. 
classification, segmentation) corresponding to the challenge. 
The abstract should serve as a high-level summary of the 
challenge purpose, design and results and report the main 
conclusions. The keywords should comprise the main terms 
characterizing the challenge. 
 
B. Introduction: Research Context 
The first section should provide the challenge motivation 
and objectives from both a biomedical and technical point of 
view. It should summarize the most important related work 
and clearly outline the expected impact of the challenge 
compared to previous studies. The task to be solved/ addressed 
by the challenge should be explicitly stated, and the section 
should clarify whether the challenge mainly focuses on 
comparative benchmarking of existing solutions or whether 
there is a necessity of improving existing solutions. 
C. Methods: Reporting of challenge design 
The challenge design parameters to be reported are 
classified in four categories related to the topics challenge 
organization, mission of the challenge, challenge data sets, 
and assessment method. The following paragraphs summarize 
the information that should be provided in the corresponding 
subsections. 
 
 
 
1) Challenge organization 
This section should include all of the relevant information 
regarding challenge organization and participation conditions. 
This information can either be reported in the main document 
or be provided as supplementary information (e.g. using the 
form provided in Suppl 1). It should include the challenge 
name (including acronym (if any)) as well as information on 
the  organizing team and the intended challenge life cycle type. 
Note that not every challenge closes after the submission 
deadline (one-time event). Sometimes it is possible to submit 
results after the deadline (open call/continuous benchmarking) 
or the challenge is repeated with some modifications (repeated 
event). Information on challenge venue and platform should 
include the event (e.g. conference, if any) that the challenge 
was associated with, the platform that was applied to run the 
challenge as well as a link to the challenge website (if any). 
 
Comprehensive information about participation policies 
should be related to the interaction level policy (e.g. only 
fully-automatic methods allowed), the training data policy 
(indicating which data sets could be used to complement the 
data sets provided by the challenge (if any)), the award policy, 
which typically refers to challenge prizes and the results 
announcements (e.g. only names of top 3 performing teams 
will be publicly announced). It should also contain 
information about the organizer participation policy. A policy 
related to this aspect may be, for example, that members of the 
organizers' institutes could participate in the challenge but 
were not eligible for awards and are not listed in the 
leaderboard. Crucially, annotators of the test data should 
generally not be allowed to annotate additional training data 
that is exclusively provided to only one/some of the 
participating teams (Remark of the authors: Such a case of 
intentional or unintentional “cheating” has occurred in the 
past). Finally, details on the publication policy should be 
provided: Do all participating teams automatically qualify as 
co-authors? Or only the top performing ones (theoretically, 
this could prevent people from participating with an arbitrary 
method just for the sake of being an author of a highly cited 
paper)? Who of the participating teams' members qualifies as 
an author (e.g. fixed maximum number per team? All team 
members? First author and supervisor (if any)?)? Can the 
participating teams publish their results separately? If so: 
After an embargo?) 
 
The section should further contain information on the 
submission method, preferably including a link to the 
instructions that the participating teams received. It should 
also include information on the procedure for evaluating the 
algorithms before the best runs/the final method were 
submitted for final performance assessment. 
 
Information on the challenge schedule should focus on the 
time(s) of training, validation (if any) and test data release as 
well as on the submission of algorithm results on test data, the 
associated workshop days (if any) and the release date of the 
results. In some challenges, a post-competition collaborative 
phase can take place, where e.g. top teams are brought 
together to further improve on solutions. This should be 
explicitly mentioned in the schedule. 
Crucially, information related to the challenge 
organization should include information on the ethics 
approval (if applicable) and the  data usage agreement 
(indicating who may use the data for which purposes under 
which conditions). Similarly, information on code availability 
should be provided explicitly relating to both the organizers' 
and the participating teams' software. To make conflicts of 
interest transparent, the section should also list the 
funding/sponsoring associated with the challenge and should 
explicitly state who had access to the test case(s) labels and 
when. Finally, the author contributions should be explicitly 
listed in the supplementary material.   
 
2) Mission of the challenge 
This paragraph should state the biomedical application 
(field of application, e.g. diagnosis, screening, intervention 
planning) and the task category (e.g. segmentation, 
classification, retrieval, detection) that the participating teams' 
algorithms were designed for. To refer to the subjects (e.g. 
patients)/objects (physical phantoms) from whom/which the 
image data was acquired, we use the term cohort. The paper 
should explicitly distinguish between the target cohort, which 
refers to the subject(s)/object(s) from whom/which the data 
would be acquired in the final biomedical application (e.g. 
healthy subjects from Germany who undergo screening) and 
the challenge cohort, defined as the subject(s)/object(s) from 
whom/which the challenge data was acquired (e.g. white male 
healthy subjects from Germany who participated in a 
voluntary study X). Note that this differentiation is crucial to 
understand the potential “domain gap”' when transferring 
challenge results to the actual application. Important 
differences may be related to various aspects including the 
subject(s)/object(s) from whom/which the image data are 
acquired (e.g. cancer patients in real application vs. porcine 
models in a challenge), the image data (e.g. various CT 
scanners in real application vs. a specific scanner in the 
challenge) and the data (e.g. fraction of malignant cases in real 
world vs. equal number of malignant and benign cases in the 
challenge). 
 
To describe the cohorts in detail, the section should also 
include information on the imaging modalities, and additional 
context information (e.g. clinical data) acquired. Most 
challenges performed to date are based solely on images and 
corresponding reference annotations (e.g. tumor labels), yet an 
increasing number of competitions provide further 
information on the patients, such as general information (age, 
gender), or laboratory results. 
 
The section should further state the target entity(ies) which 
includes  the data origin, i.e. the region from which the image 
data are acquired (e.g. scan of the head, video of the whole 
operating theater) and the algorithm target defined as the 
structure (e.g. tumor in the brain)/object (e.g. robot)/subject 
(e.g. nurse)/component (e.g. tip of a medical instrument) that 
the participating algorithms focus on. 
 
Finally, it should provide a concise statement of the 
assessment aim(s) (e.g. finding the most sensitive lesion 
detection algorithm vs. identifying the fastest algorithm that 
provides a median detection accuracy below a certain 
threshold). The metric(s) and ranking scheme chosen 
(parameters 29 and 30 in assessment method, Appendix A) 
should reflect the assessment aims as closely as possible, i.e. 
optimizing the metrics will ideally optimize the properties of 
the algorithm that are important according to the assessment 
aim. Note that it is necessary to make the assessment aim 
explicit, as it may not be straightforward to find an appropriate 
metric for certain properties to be optimized. 
 
3) Challenge data sets 
While the information contained in the challenge mission 
section should refer to both the target cohort and the challenge 
cohort, this section is exclusively dedicated to the challenge 
cohort. It should start with a description on the data source(s). 
This should include information on specific acquisition 
devices (e.g. the specific type of magnetic resonance imaging 
(MRI) scanner used), acquisition protocols (e.g. the specific 
MRI imaging protocol applied) as well as centers/data 
providing source(s) and operators that were involved in the 
data acquisition (e.g. a specific robot in a specific university 
clinic). If the centers involved cannot be mentioned due to 
requirements for anonymity, this should be made explicit. 
Information on the operators should focus on the relevant 
information in the challenge context. It may, for example, be 
irrelevant to state the years of experience of the person 
acquiring an MRI image according to an established protocol 
whereas, for data derived from a complex surgical procedure, 
it may be crucially important to explicitly list the level of 
expertise of the surgeon. 
 
The section should further provide information on the 
training and test case characteristics. It should begin by 
stating explicitly what data encompasses a single case, i.e. 
which data are meant to be processed to produce one result 
that is compared to the corresponding reference result. 
Information on the cases should further include information 
on the number of training/test cases as well as on why a 
specific proportion of training/test data was chosen, why a 
certain total number of cases was chosen and why certain 
characteristics were chosen for the training/test set (e.g. class 
distribution according real-world distribution vs. equal class 
distribution). 
 
Information on the annotation characteristics should 
begin by describing the general approach to training/test case 
annotation (e.g. annotation of the test data by a medical expert 
vs. annotation of the training data via crowdsourcing such as 
in [27]). It should include the instructions given to the 
annotators prior to the annotation, details on the 
subject(s)/algorithm(s) that annotated the cases (e.g. 
information on level of expertise such as number of years of 
professional experience, medically-trained or not) and the 
method(s) used to merge multiple annotations for one case. 
All information should be provided separately for the training, 
validation and test cases if necessary. 
 
Data pre-processing methods (if any) used to process the 
raw data should also be well-described and justified. 
Crucially, potential sources of errors related to the annotation 
but also the data acquisition should be comprehensively 
described. Sources of error related to the data acquisition may, 
for example, refer to calibration errors of the image modality, 
tracking errors related to pose computation of surgical 
instruments or errors resulting from substantial motion during 
image acquisition. Preferably, a quantitative analysis (e.g. 
using the concept of intra-annotator and inter-annotator 
variability) should be performed to estimate the magnitude of 
the different error sources. 
 
4) Assessment method 
The metric(s) to assess a property of an algorithm should 
be well-explained including the parameters used (if any) and 
preferably with reference to a paper. The metrics should be 
justified in the context of the challenge objective (parameter 
assessment aim(s) and the biomedical application. For 
example, the Dice similarity coefficient (DSC) is a well-suited 
metric for assessing segmentation accuracy for large 
structures, such as organs in images, but is not well-suited for 
quantifying segmentation accuracy in the case of small 
pathologies.   
 
If one or multiple rankings were generated for the 
challenge, the ranking method(s) should be specified by 
describing how metric values are aggregated/used to generate 
a final ranking (if any). It should also provide information on 
the rank value in case of tied positions, as well as on methods 
used to manage submissions with missing results on test cases 
(missing data handling) and to handle any diversity in the level 
of user interaction when generating the performance ranking 
(interaction level handling). The section should further make 
explicit how the ranking chosen matches the assessment aim. 
 
Details for all the statistical methods used to analyze the 
data should be provided. If results on test cases were entered 
as missing values, it should be described how these were 
handled in the statistical analyses. Further, details about the 
assessment of the robustness of the ranking should be 
provided. If statistical hypothesis tests were used to compare, 
e.g. participating teams, details about the statistical method 
should be provided including a description on any method 
used to assess whether the data met the assumptions required 
for the particular statistical approach. For all data analysis 
methods, the software product used should be mentioned. 
Preferably, the code should also be released along with the 
paper.    
 
Further analyses performed should also be reported in this 
section. This includes experiments based on combining 
individual algorithms via ensembling and experiments on 
inter-algorithm variability, for example. 
 
D. Results: Reporting of Challenge Outcome 
We suggest subdividing the outcome section into five 
categories: Challenge submission, information on selected 
participating teams, metric values, rankings and further 
analyses. 
 
At first, information on the submissions received should 
be summarized. This includes the number of registrations, the 
number of (valid) submissions (if applicable: in each phase) 
and the number of participating teams that the challenge 
paper is about (selected participating teams) with justification 
why these participating teams were chosen (e.g. top n 
performing teams; teams with a metric value above a 
threshold; m% top performing teams). Depending on the 
number of participating teams, information on selected 
participating teams can be provided in the main document or 
in the appendix. Information on those teams referred to in the 
results section should include a team identifier (as name of 
the team) as well as a description of the method. The latter 
can for example be a brief textual summary plus a link to a 
document that provides detailed information not only on the 
basic method but also on the specific parameters 
(/optimizations) performed for the challenge. Ideally, this 
reference document should also provide information on 
complexity analysis with respect to time and memory 
consumption, hardware/OS requirements and reference to the 
source code. 
 
Depending on the number of test cases and participating 
teams, raw metric values (i.e. metric values for each test case) 
and/or aggregated metric values should be provided for all 
participating teams/the selected teams. Parts of these results 
may be moved to the appendix. 
 
The ranking(s) (if any) should be reported including the 
results on robustness analyses (e.g. bootstrapping results) and 
other statistical analyses. Again, depending on the number of 
participating teams, the paper may refer to only the top 
performing teams (referred to as selected participating teams 
above). Depending on the number of participating teams, full 
(if necessary partially anonymized) ranking(s) should be 
provided in the main document, as supplementary material or 
in another citable document. 
 
The results of further analyses performed (if any) should 
also be reported in this section. This includes analyses of 
common problems/biases of the methods. 
 
E. Discussion: Putting the Results into Context 
The final section should provide a concise summary of the 
challenge outcome and discuss the findings of the challenge 
thoroughly in the context of the state of the art. It should 
clearly distinguish between the technical and biomedical 
impact. Current performance of the best methods should be 
discussed and conclusions drawn about whether the task is 
already solved in a satisfactory way (e.g. the remaining errors 
are comparable to inter-annotator variability). Furthermore, an 
analysis of individual cases, in which the majority of 
algorithms performed poorly (if any), should be included. 
Also, advantages and disadvantages of the participating 
methods should be discussed. In this context, it should be 
made explicit whether an algorithm with clearly superior 
performance could be identified or if more than one algorithm 
is well-suited for the specific task. Furthermore, limitations of 
the challenge should be made explicit (design and execution). 
Finally, concrete recommendations for future work should be 
provided and a conclusion drawn. 
 
 
III. DISCUSSION 
As a first step to address the discrepancy between 
the impact of biomedical image analysis challenges and the 
quality (control), the BIAS initiative aims to improve the 
transparency of the reporting. This article describes how the 
BIAS statement was developed and presents a checklist 
which authors of biomedical image analysis challenges are 
encouraged to include in their submission when giving a 
challenge paper into review. By making relevant information 
explicit, the checklist has the purpose to standardize and 
facilitate the reviewing/editorial process and raise 
interpretability and reproducibility of challenge results. 
 
The checklist generated in the scope of this article 
relies heavily on the challenge parameter list published in our 
previous work [18]. In the meantime, this parameter list has 
been instantiated with more than 500 tasks from more than 
150 challenges, both retrospectively [18] and prospectively 
in the scope of the structured challenge submission system 
used for MICCAI 2018 and 2019. According to our 
experience, the (updated) list presented in this work should 
be appropriate to capture the relevant information on current 
challenge design and organization. It is worth noting, 
however, that an update of the checklist may be required at a 
later point of time. For example, ongoing research is 
investigating the generation of probabilistic output for a 
whole range of algorithm categories [28]; rather than 
providing a single contour as result for a segmentation task. 
For instance, such methods produce a whole range of 
plausible solutions via sampling. It is currently unknown how 
such output may be efficiently handled in the design of future 
challenges.   
 
An increasingly relevant problem is that it typically 
remains unknown which specific feature of one algorithm 
actually makes it better than competing algorithms [18]. For 
example, many researchers are convinced that the method for 
data augmentation often has a much bigger influence on the 
performance of a deep learning algorithm than the network 
architecture itself. For this reason, a structured description 
(e.g. using ontologies) not only of the challenge but also of 
the participating algorithms may be desirable. Due to the lack 
of common software frameworks and terminology, however, 
this is not trivial to implement at this stage [18]. 
 
It is worth mentioning that our guideline has 
explicitly been developed for reporting the design and results 
for one task of a challenge. If a challenge includes multiple 
tasks, the results should preferably be reported in separate 
publications. If this is not desirable (i.e. a single paper refers 
to multiple tasks with substantial overlap between tasks such 
as tasks sharing the same data sets), a separate checklist for 
each task should be generated. Alternatively, a single 
checklist may be provided in which some items are common 
to all tasks and other items contain separate parts for each 
task. 
 
It should also be noted that challenges could in 
theory focus on collaboration rather than competition.  In 
such collaborative challenges, the participating teams would 
work jointly on a dedicated problem, and the focus would be 
on solving a problem together rather than benchmarking 
different methods. We have not explicitly addressed such 
collaborative challenges with the checklist. 
 
We believe that the work invested to improve 
challenge reporting could also be valuable in guiding 
challenge design. For this reason, we have converted the 
reviewer checklist into a document that can be used to 
comprehensively report the envisioned design of a challenge 
and could thus be used to review a challenge before it is 
organized (Suppl 2). Based on this document, the MICCAI 
society and MICCAI 2020 organizing team decided to 
introduce the concept of challenge registration. Similar to 
how clinical trials have to be registered before they are 
started, the complete design of accepted MICCAI challenges 
had to be put online before challenge execution. This was 
achieved with Zenodo 1 , a general-purpose open-access 
repository that allows researchers to deposit data sets, 
software, and other research-related items. Such stored items 
are citable, because a persistent digital object identifier (DOI) 
is generated for each submission. As Zenodo also supports 
version control, changes to a challenge design (e.g. to the 
metrics or ranking schemes applied) can be made transparent. 
These changes must be communicated to the MICCAI society 
and be well-justified. To date (June 2020), 8 out of the 28 
challenges committed changes to the designs, originally 
uploaded in April 2020. Most of them were changes to the 
schedule, which can be attributed to the COVID-19 outbreak. 
We believe that the transparency and quality control that 
comes along with challenge registration is a big step towards 
higher quality of biomedical challenges. 
 
Challenges are becoming increasingly important in 
various fields, ranging from protein structure, to systems 
biology, text mining, and genomics, thanks to initiatives such 
as CASP (Critical Assessment of Techniques for Protein 
Structure Prediction) [29], BioCreative (Critical Assessment 
of Information Extraction in Biology [30]), DREAM 
(Dialogue for Reverse Engineering Assessment and Methods 
[25]), and CAGI (Critical Assessment of Genome 
Interpretation [31]). The checklist and the challenge design 
document could be adapted to these research areas and thus 
contribute substantially to better scientific practice related to 
challenges in general. 
 
In conclusion, this document is the first to provide a 
guideline for the reporting of a biomedical image analysis 
challenge regardless of field of application, image modality 
or algorithm category assessed. We hope that the checklist 
provided will help editors of journals in the field of 
biomedical image analysis and beyond to establish a rigorous 
review process with the mid-term goal of increasing 
interpretability and reproducibility of results and raising the 
quality of challenge design in general. 
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Section/ Topic Parameter name 
Item 
No 
Checklist Item 
Reported 
on page 
No 
TITLE, ABSTRACT, 
KEYWORDS 
Title 1 Use the title to convey the essential information on the challenge mission.  
The title should ... 
● … identify the paper as biomedical image analysis challenge. 
● … indicate the image modality(ies) applied with a commonly used term in the title. 
● … indicate the task and/or task category (e.g. classification, segmentation; see 
parameter 18) with a commonly used term in the title. 
● … (optionally) include information on the biomedical target application. 
● … (optionally) include the year for repeated challenges with fixed cycle. 
 
Abstract 2 Provide a summary of the challenge purpose, design and results and report the main 
conclusion(s). 
 
Keywords 3 List the primary keywords that characterize the challenge.  
INTRODUCTION Challenge 
motivation and 
objective 
4a Provide a general introduction to the topic from a biomedical point of view. This should 
include the envisioned biomedical impact (short-term and/or long-term). 
 
4b Provide a general introduction to the topic from a technical point of view. This should 
include an overview of the state of the art along the envisioned 
technical/methodological impact. 
 
4c Based on the biomedical and technical motivation, provide a concise statement of the 
primary challenge objective. This should include a statement of the task. 
 
METHODS 
Challenge 
organization 
Challenge name 5a Provide a representative name of the challenge. 
Example: MICCAI Endoscopic Vision Challenge 2015 
 
5b Provide the acronym of the challenge (if any). 
Example: EndoVis15 
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Organizing team 6 Provide information on the organizing team (names and affiliations).  
Life cycle type 7 Define the intended submission cycle of the challenge. Include information on 
whether/how the challenge has been/will be continued after the present study. 
Examples:  
● One-time event with fixed submission deadline 
● Open call 
● Repeated event with annual fixed submission deadline 
 
Challenge venue 
and platform 
8a Report the event (e.g. conference) that was associated with the challenge (if any).  
8b Report the platform (e.g. grand-challenge.org) used to run the challenge.  
8c Provide the URL for the challenge website (if any).   
Participation 
policies 
9a Define the allowed user interaction of the algorithms assessed (e.g. only (semi-) automatic 
methods allowed). 
 
9b Define the policy on the usage of training data. The data used to train algorithms may, for 
example, have been restricted to the data provided by the challenge or to publicly 
available data including (open) pre-trained nets. 
 
9c Define the participation policy for members of the organizers' institutes. For example, 
members of the organizers' institutes could participate in the challenge but were not 
eligible for awards.  
 
9d Define the award policy. In particular, provide details with respect to challenge prizes.   
9e Define the policy for results announcement. 
Examples: 
● Top three performing methods were announced publicly. 
● Participating teams could choose whether the performance results will be made 
public. 
 
9f Define the publication policy. In particular, provide details on ...  
● … who of the participating teams/the participating teams’ members qualified as 
author 
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● … whether the participating teams could publish their own results separately, and 
(if so) 
● … whether an embargo time was defined (so that challenge organizers can 
publish a challenge paper first). 
Submission 
method 
10a Describe the method used for result submission. If available, provide a link to the 
submission instructions. 
Examples: 
● Docker container on the Synapse platform. Link to submission instructions: <URL> 
● Algorithm output was sent to organizers via e-mail. Submission instructions were 
sent by e-mail. 
 
10b Provide information on the possibility for participating teams to evaluate their algorithms 
before submitting final results. For example, many challenges allow submission of multiple 
results, and only the last run is officially counted to compute challenge results. 
 
Challenge 
schedule 
11 Provide a timetable for the challenge. Preferably, this should include 
● the release date(s) of the training cases (if any) 
● the registration date/period 
● the release date(s) of the test cases and validation cases (if any) 
● the submission date(s) 
● associated workshop days (if any) 
● the release date(s) of the results 
 
Ethics approval 12 Indicate whether ethics approval was necessary for the data. If yes, provide details on the 
ethics approval, preferably institutional review board, location, date and number of the 
ethics approval (if applicable). Add the URL or a reference to the document of the ethics 
approval (if available). 
 
Data usage 
agreement 
13 Clarify how the data can be used and distributed by the teams that participate in the 
challenge and by others. This should include the explicit listing of the license applied. 
Examples: 
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● CC BY (Attribution) 
● CC BY-SA (Attribution-ShareAlike) 
● CC BY-ND (Attribution-NoDerivs) 
● CC BY-NC (Attribution-NonCommercial) 
● CC BY-NC-SA (Attribution-NonCommercial-ShareAlike) 
● CC BY-NC-ND (Attribution-NonCommercial-NoDerivs) 
Code availability 14a Provide information on the accessibility of the organizers' evaluation software (e.g. code 
to produce rankings). Preferably, provide a link to the code and add information on the 
supported platforms. 
 
14b In an analogous manner, provide information on the accessibility of the participating 
teams' code. 
 
Conflicts of 
interest 
15 Provide information related to conflicts of interest. In particular provide information related 
to sponsoring/funding of the challenge. Also, state explicitly who had access to the test 
case labels and when. 
 
Author 
contributions 
16 List the contributions of all authors to the paper (preferably in the appendix).  
METHODS 
Mission of the 
challenge 
Field(s) of 
application 
17 State the main field(s) of application that the participating algorithms target. 
Examples: 
● Diagnosis 
● Education 
● Intervention assistance 
● Intervention follow-up 
● Intervention planning 
● Prognosis 
● Research 
● Screening 
● Training 
● Cross-phase 
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Task 
category(ies) 
18 State the task category(ies). 
Examples: 
● Classification 
● Detection 
● Localization 
● Modeling 
● Prediction 
● Reconstruction 
● Registration 
● Retrieval 
● Segmentation 
● Tracking 
 
Cohorts We distinguish between the target cohort and the challenge cohort. For example, a challenge 
could be designed around the task of medical instrument tracking in robotic kidney surgery. While 
the challenge could be based on ex vivo data obtained from a laparoscopic training 
environment with porcine organs (challenge cohort), the final biomedical application (i.e. robotic 
kidney surgery) would be targeted on real patients with certain characteristics defined by 
inclusion criteria such as restrictions regarding gender or age (target cohort). 
 
19a Describe the target cohort, i.e. the subjects/objects from whom/which the data would be 
acquired in the final biomedical application. 
 
19b Describe the challenge cohort, i.e. the subject(s)/object(s) from whom/which the 
challenge data was acquired. 
 
Imaging 
modality(ies) 
20 Specify the imaging technique(s) applied in the challenge.  
Context 
information 
Provide additional information given along with the images. The information may correspond ...  
21a … directly to the image data (e.g. tumor volume). If necessary, differentiate between 
target and challenge cohort. 
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21b … to the patient in general (e.g. gender, medical history). If necessary, differentiate 
between target and challenge cohort. 
 
21c … to the acquisition process (e.g. medical device data during endoscopic surgery, 
calibration data for an image modality). If necessary, differentiate between target and 
challenge cohort. 
 
Target entity(ies) 22a Describe the data origin, i.e. the region(s)/part(s) of subject(s)/object(s) from whom/which 
the image data would be acquired in the final biomedical application (e.g. brain shown 
in computed tomography (CT) data, abdomen shown in laparoscopic video data, 
operating room shown in video data, thorax shown in fluoroscopy video). If necessary, 
differentiate between target and challenge cohort. 
 
22b Describe the algorithm target, i.e. the structure(s)/subject(s)/object(s)/component(s) that 
the participating algorithms have been designed to focus on (e.g. tumor in the brain, tip 
of a medical instrument, nurse in an operating theater, catheter in a fluoroscopy scan). If 
necessary, differentiate between target and challenge cohort. 
 
Assessment 
aim(s) 
23 Identify the property(ies) of the algorithms to be optimized to perform well in the 
challenge. If multiple properties were assessed, prioritize them (if appropriate). The 
properties should then be reflected in the metrics applied (parameter 29), and the 
priorities should be reflected in the ranking when combining multiple metrics that assess 
different properties. 
● Example 1: Find liver segmentation algorithm for CT images that processes CT 
images of a certain size in less than a minute on a certain hardware with an error 
that reflects inter-rater variability of experts. 
● Example 2: Find lung tumor detection algorithm with high sensitivity and specificity 
for mammography images. 
Corresponding metrics are listed below (parameter 29). 
 
METHODS Data source(s) 24a Specify the device(s) used to acquire the challenge data. This includes details on the 
device(s) used to acquire the imaging data (e.g. manufacturer) as well as information on 
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Challenge data 
sets 
additional devices used for performance assessment (e.g. tracking system used in a 
surgical setting). 
24b Describe relevant details on the imaging process/data acquisition for each acquisition 
device (e.g. image acquisition protocol(s)). 
 
24c Specify the center(s)/institute(s) in which the data was acquired and/or the data 
providing platform/source (e.g. previous challenge). If this information is not provided (e.g. 
for anonymization reasons), specify why. 
 
24d Describe relevant characteristics (e.g. level of expertise) of the subjects (e.g. 
surgeon)/objects (e.g. robot) involved in the data acquisition process (if any). 
 
Training and test 
case 
characteristics 
25a State what is meant by one case in this challenge. A case encompasses all data that is 
processed to produce one result that is then compared to the corresponding reference 
result (i.e. the desired algorithm output). 
Examples: 
● Training and test cases both represented a CT image of a human brain. Training 
cases had a weak annotation (tumor present or not and tumor volume (if any)) 
while the test cases were annotated with the tumor contour (if any). 
● A case refers to all information that is available for one particular patient in a 
specific study. This information always includes the image information as specified 
in data source(s) (parameter 24) and may include context information (parameter 
21). Both training and test cases were annotated with survival (binary) 5 years after 
(first) image was taken. 
 
25b State the total number of cases as well as the number of training, validation and test cases 
separately. 
 
25c Explain why a total number of cases and the specific proportion of training, validation and 
test cases was chosen. 
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25d Mention further important characteristics of the training, validation and test cases (e.g. 
class distribution in classification tasks chosen according to real-world distribution vs. equal 
class distribution) and justify the choice. 
 
Annotation 
characteristics 
26a Describe the method for determining the reference annotation, i.e. the desired algorithm 
output. Provide the information separately for the training, validation and test cases if 
necessary. Possible methods include manual image annotation, in silico ground truth 
generation and annotation by automatic methods. 
If human annotation was involved, state the number of annotators. 
 
26b Provide the instructions given to the annotators (if any) prior to the annotation. This may 
include description of a training phase with the software. Provide the information 
separately for the training, validation and test cases if necessary. Preferably, provide a link 
to the annotation protocol. 
 
26c Provide details on the subject(s)/algorithm(s) that annotated the cases (e.g. information 
on level of expertise such as number of years of professional experience, medically-
trained or not). Provide the information separately for the training, validation and test 
cases if necessary.  
 
26d Describe the method(s) used to merge multiple annotations for one case (if any). Provide 
the information separately for the training, validation and test cases if necessary.  
 
Data pre-
processing 
method(s) 
27 Describe the method(s) used for pre-processing the raw training data before it is provided 
to the participating teams. Provide the information separately for the training, validation 
and test cases if necessary.  
 
Sources of error 28a Describe the most relevant possible error sources related to the image annotation. If 
possible, estimate the magnitude (range) of these errors, using inter-and intra-annotator 
variability, for example. Provide the information separately for the training, validation and 
test cases, if necessary.  
 
28b In an analogous manner, describe and quantify other relevant sources of error.   
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METHODS 
Assessment 
methods 
Metric(s) 29a Define the metric(s) to assess a property of an algorithm. These metrics should reflect the 
desired algorithm properties described in assessment aim(s) (parameter 21). State which 
metric(s) were used to compute the ranking(s) (if any). 
● Example 1: Dice Similarity Coefficient (DSC) and run-time 
● Example 2: Area under curve (AUC) 
 
29b Justify why the metric(s) was/were chosen, preferably with reference to the biomedical 
application. 
 
Ranking 
method(s) 
30a Describe the method used to compute a performance rank for all submitted algorithms 
based on the generated metric results on the test cases. Typically the text will describe 
how results obtained per case and metric are aggregated to arrive at a final 
score/ranking. 
 
30b Describe the method(s) used to manage submissions with missing results on test cases.  
30c Justify why the described ranking scheme(s) was/were used.  
Statistical 
analyses 
31a Provide details for all statistical methods used in the scope of the challenge analysis. This 
may include 
● description of the missing data handling,  
● details about the assessment of variability of rankings,  
● description of any method used to assess whether the data met the assumptions, 
required for the particular statistical approach, or 
● indication of any software product that was used for data analysis. 
 
31b Justify why the described statistical method(s) was/were used.  
RESULTS 
Challenge 
outcome 
Challenge 
submissions 
Provide summarizing information on ...  
32a … the number of registrations.  
32b … the number of participating teams that provided valid submissions (if applicable in each 
phase). 
 
32c … the number of participating teams that the paper refers to (with justification).  
Provide the following information for the participating teams that are included in the paper:  
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Information on 
selected 
participating 
teams 
33a Team identifier.  
33b A method description including parameter instantiation and/or a reference/URL to a 
document containing this information. 
 
Metric values 34 Provide raw and/or aggregated metric values (including measure of variability) for all 
participating teams and each metric (if applicable) as well as the numbers of test set 
submissions (the last one was used to compute metric(s)) for each participating team. 
 
Ranking(s) 35a Report the ranking(s) (if any) including the number of test set submissions for each 
participating team. 
 
35b Provide the results of the statistical analyses.  
Further Analyses 36 Present results of further analyses (if applicable), e.g. related to  
● combining algorithms via ensembling, 
● inter-algorithm variability, 
● common problems/biases of the submitted methods, or 
● ranking variability. 
 
DISCUSSION Summary 37 Summarize the main results of the challenge.  
Impact 38a Describe the (expected) biomedical impact of the challenge in the context of the state of 
the art with reference to the challenge motivation (parameter 4a). 
 
38b Describe the (expected) technical impact of the challenge in the context of the state of 
the art with reference to the challenge motivation (parameter 4b). 
 
Discussion of 
challenge results 
39a Provide a detailed discussion and conclusion whether the task is now solved in a 
satisfactory way (e.g. the remaining errors are comparable to inter-annotator variability). 
 
39b Provide a detailed analysis of individual cases, in which the majority of algorithms 
performed poorly (if any). 
 
39c Provide a discussion on advantages and disadvantages of the submitted methods. 
Include time and memory consumption comparison if time and memory were not among 
the metrics. 
 
Limitations of the 
challenge 
40 Discuss limitations related to the challenge design and execution.   
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Future work 41 Provide recommendations for future work and maintenance plans for the challenge and 
its website (if any). 
 
Conclusions 42 Provide a concise conclusion based on the results of the study.  
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Term Explanation 
Biomedical image 
analysis challenge 
Open competition on a specific scientific problem in the field of biomedical image 
analysis. 
Case  Data set for which the algorithm(s) of interest produce one result in either the 
training phase (if any) or the test phase. It must include one or multiple images of 
a biomedical imaging modality (e.g. a computed tomography (CT) and a 
magnetic resonance imaging (MRI) image of the same structure) and comprises a 
reference annotation (public for the training phase and secret for the test phase). 
Cohort Term used to refer to the subjects (e.g. patients) or objects (e.g. physical phantoms) 
from which the image data was acquired. The paper should explicitly distinguish 
between the target cohort, which refers to the subjects/objects from whom/which 
the data would be acquired in the final medical/biological application (e.g. 
healthy subjects from Germany that undergo screening) and the challenge 
cohort, defined as the subject(s)/object(s) from whom/which the challenge data 
was acquired (e.g. white male healthy subjects from Germany that participated in 
a voluntary study X). Note that this differentiation is crucial to understand the 
potential “domain gap” when transferring challenge results to the actual 
application. 
DREAM Challenges Dialogue for Reverse Engineering Assessments and Methods Challenges. Non-
profit, collaborative community effort consisting of contributors from across the 
research spectrum, with a focus on systems biology. 
Dry run phase Challenge phase in which the challenge organizers themselves work with the data 
to determine the level of difficulty of the task(s), for example by building simple 
models to solve the challenge. 
Final biomedical 
application 
Biomedical application that algorithms participating in a challenge are designed 
for. 
Leaderboard  Ranking of the challenges’ participating teams or one of its tasks that is generated 
or updated by the challenge organizers. 
Metric  A measure (not necessarily metric in the strict mathematical sense) used to 
compute the performance of a given algorithm for a given case, typically based 
on the reference annotation. 
Ranking scheme Algorithm according to which a ranking of the participating teams is produced 
based on the metric values for the test cases of the challenge. 
Reference annotation Desired result (available for each test case and typically also for a significant 
number of training cases) to which the computed results of the participating teams 
are compared to. The term reference annotation (alternatively: gold standard if 
produced manually or silver standard if produced by merging multiple computer-
 
 
 
Appendix B: Glossary 
generated results) is preferred over ground truth because reference annotations 
are typically only approximations of the (forever unknown) truth (except for the 
case of synthetic data). 
Sage/Synapse 
platform 
Non-profit biomedical research organization dedicated to developing predictors 
of disease and accelerating health research through the creation of open systems, 
incentives, and standards.  
Task  Subproblem to be solved in the scope of a challenge for which a dedicated 
ranking/leaderboard is provided (if any). The assessment method (e.g. metric(s) 
applied) may vary across different tasks of a challenge. 
Test phase Challenge phase in which participants either upload their algorithm, or they get 
access to the test cases without the reference annotations and submit the results 
of their algorithm on the test cases to the challenge organizers. 
Training phase  Phase at the beginning of the challenge in which the challenge organizers provide 
access to training cases with corresponding reference annotations. 
Validation phase Challenge phase between training and test phase in which initial rankings 
(leaderboards) are generated to show participants how well their methods 
generalize. Sometimes also referred to as leaderboard phase. 
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Suppl 1: Form for summarizing  
information on challenge organization 
 
Challenge name 
a) Provide a representative name of the challenge. 
Example: MICCAI Endoscopic Vision Challenge 2015 
 
 
 
b) Provide the acronym of the challenge (if any). 
Example: EndoVis15 
 
 
 
 
Organizing team 
Provide information on the organizing team (names and affiliations). 
 
 
 
 
Life cycle type 
Define the intended submission cycle of the challenge. Include information on 
whether/how the challenge has been/will be continued after the present study. 
Examples:  
● One-time event with fixed submission deadline 
● Open call 
● Repeated event with annual fixed submission deadline 
 
 
 
 
Challenge venue and platform 
a) Report the event (e.g. conference) that was associated with the challenge (if 
any). 
 
 
 
b) Report the platform (e.g. grand-challenge.org) used to run the challenge. 
 
 
 
c) Provide the URL for the challenge website (if any). 
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Participation policies 
a) Define the allowed user interaction of the algorithms assessed (e.g. only (semi-) 
automatic methods allowed). 
 
 
 
b) Define the policy on the usage of training data. The data used to train algorithms 
may, for example, have been restricted to the data provided by the challenge or to 
publicly available data including (open) pre-trained nets. 
 
 
 
c) Define the participation policy for members of the organizers' institutes. For 
example, members of the organizers' institutes could participate in the challenge but 
were not eligible for awards. 
 
 
 
d) Define the award policy. In particular, provide details with respect to challenge 
prizes. 
 
 
 
e) Define the policy for results announcement. 
Examples: 
● Top three performing methods were announced publicly. 
● Participating teams could choose whether the performance results will be made 
public. 
 
 
 
f) Define the publication policy. In particular, provide details on ...  
● … who of the participating teams/the participating teams’ members qualified as 
author 
● … whether the participating teams could publish their own results separately, and (if 
so) 
● … whether an embargo time was defined (so that challenge organizers can publish a 
challenge paper first). 
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Submission method 
a) Describe the method used for result submission. If available, provide a link to the 
submission instructions. 
 
 
 
b) Provide information on the possibility for participating teams to evaluate their 
algorithms before submitting final results. For example, many challenges allow 
submission of multiple results, and only the last run is officially counted to compute 
challenge results. 
 
 
 
 
Challenge schedule 
Provide a timetable for the challenge. Preferably, this should include 
● the release date(s) of the training cases (if any) 
● the registration date/period 
● the release date(s) of the test cases and validation cases (if any) 
● the submission date(s) 
● associated workshop days (if any) 
● the release date(s) of the results 
 
 
 
 
Ethics approval 
Clarify how the data can be used and distributed by the teams that participate in 
the challenge and by others. This should include the explicit listing of the license 
applied. 
Examples: 
● CC BY (Attribution) 
● CC BY-SA (Attribution-ShareAlike) 
● CC BY-ND (Attribution-NoDerivs) 
● CC BY-NC (Attribution-NonCommercial) 
● CC BY-NC-SA (Attribution-NonCommercial-ShareAlike) 
● CC BY-NC-ND (Attribution-NonCommercial-NoDerivs) 
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Data usage agreement 
a) Provide information on the accessibility of the organizers' evaluation software (e.g. 
code to produce rankings). Preferably, provide a link to the code and add 
information on the supported platforms. 
 
 
 
b) In an analogous manner, provide information on the accessibility of the 
participating teams' code. 
 
 
 
 
Code availability 
Provide information related to conflicts of interest. In particular provide information 
related to sponsoring/ funding of the challenge. Also, state explicitly who had 
access to the test case labels and when. 
 
 
 
 
Conflicts of interest 
List the contributions of all authors to the paper (preferably in the appendix). 
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Suppl 2: Structured description of a  
challenge design  
 
SUMMARY 
 
Item 1: Title 
a) Use the title to convey the essential information on the challenge mission. 
 
 
 
 
b) Preferable, provide a short acronym of the challenge (if any). 
 
 
 
 
Item 2: Abstract 
Provide a summary of the challenge purpose. This should include a general introduction 
in the topic from both a biomedical as well as from a technical point of view and clearly 
state the envisioned technical and/or biomedical impact of the challenge. 
 
 
 
 
Item 3: Keywords 
List the primary keywords that characterize the challenge. 
 
 
 
 
 
CHALLENGE ORGANIZATION 
 
Item 4: Organizers 
a) Provide information on the organizing team (names and affiliations). 
 
 
 
 
b) Provide information on the primary contact person. 
 
 
 
 
 Suppl 2: Structured description of a challenge design 
Item 5: Lifecycle type 
Define the intended submission cycle of the challenge. Include information on 
whether/how the challenge will be continued after the challenge has taken place. 
Examples:  
● One-time event with fixed submission deadline 
● Open call 
● Repeated event with annual fixed submission deadline 
 
 
 
 
Item 6: Challenge venue and platform 
a) Report the event (e.g. conference) that is associated with the challenge (if any). 
 
 
 
 
b) Report the platform (e.g. grand-challenge.org) used to run the challenge. 
 
 
 
 
c) Provide the URL for the challenge website (if any).  
 
 
 
 
Item 7: Participation policies 
a) Define the allowed user interaction of the algorithms assessed (e.g. only (semi-) 
automatic methods allowed). 
 
 
 
 
b) Define the policy on the usage of training data. The data used to train algorithms 
may, for example, be restricted to the data provided by the challenge or to publicly 
available data including (open) pre-trained nets. 
 
 
 
 
c) Define the participation policy for members of the organizers' institutes. For example, 
members of the organizers' institutes may participate in the challenge but are not 
eligible for awards. 
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d) Define the award policy. In particular, provide details with respect to challenge 
prizes. 
 
 
 
 
e) Define the policy for result announcement. 
Examples: 
● Top three performing methods will be announced publicly. 
● Participating teams can choose whether the performance results will be made public 
 
 
 
 
f) Define the publication policy. In particular, provide details on ...  
● … who of the participating teams/the participating teams’ members qualifies as author 
● … whether the participating teams may publish their own results separately, and (if so) 
● … whether an embargo time is defined (so that challenge organizers can publish a 
challenge paper first). 
 
 
 
 
Item 8: Submission method 
a) Describe the method used for result submission. Preferably, provide a link to the 
submission instructions. 
Examples: 
● Docker container on the Synapse platform. Link to submission instructions: <URL> 
● Algorithm output was sent to organizers via e-mail. Submission instructions were sent by e-
mail. 
 
 
 
 
b) Provide information on the possibility for participating teams to evaluate their 
algorithms before submitting final results. For example, many challenges allow 
submission of multiple results, and only the last run is officially counted to compute 
challenge results. 
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Item 9: Challenge schedule 
Provide a timetable for the challenge. Preferably, this should include 
● the release date(s) of the training cases (if any) 
● the registration date/period 
● the release date(s) of the test cases and validation cases (if any) 
● the submission date(s) 
● associated workshop days (if any) 
● the release date(s) of the results 
 
 
 
 
Item 10: Ethics approval 
Indicate whether ethics approval is necessary for the data. If yes, provide details on the 
ethics approval, preferably institutional review board, location, date and number of the 
ethics approval (if applicable). Add the URL or a reference to the document of the 
ethics approval (if available). 
 
 
 
 
Item 11: Data usage agreement 
Clarify how the data can be used and distributed by the teams that participate in the 
challenge and by others during and after the challenge. This should include the explicit 
listing of the license applied. 
Examples: 
● CC BY (Attribution) 
● CC BY-SA (Attribution-ShareAlike) 
● CC BY-ND (Attribution-NoDerivs) 
● CC BY-NC (Attribution-NonCommercial) 
● CC BY-NC-SA (Attribution-NonCommercial-ShareAlike) 
● CC BY-NC-ND (Attribution-NonCommercial-NoDerivs) 
 
 
 
 
Item 12: Code availability 
a) Provide information on the accessibility of the organizers' evaluation software (e.g. 
code to produce rankings). Preferably, provide a link to the code and add information 
on the supported platforms. 
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b) In an analogous manner, provide information on the accessibility of the participating 
teams' code. 
 
 
 
 
Item 13: Conflicts of interest 
Provide information related to conflicts of interest. In particular provide information 
related to sponsoring/ funding of the challenge. Also, state explicitly who had/will have 
access to the test case labels and when. 
 
 
 
 
 
MISSION OF THE CHALLENGE 
 
Item 14: Field(s) of application 
State the main field(s) of application that the participating algorithms target. 
Examples: 
● Diagnosis 
● Education 
● Intervention assistance 
● Intervention follow-up 
● Intervention planning 
● Prognosis 
● Research 
● Screening 
● Training 
● Cross-phase 
 
 
 
 
Item 15: Task category(ies) 
State the task category(ies). 
Examples: 
● Classification 
● Detection 
● Localization 
● Modeling 
● Prediction 
● Reconstruction 
● Registration 
● Retrieval 
● Segmentation 
● Tracking 
 
 
 
 Suppl 2: Structured description of a challenge design 
Item 16: Cohorts 
We distinguish between the target cohort and the challenge cohort. For example, a 
challenge could be designed around the task of medical instrument tracking in robotic 
kidney surgery. While the challenge could be based on ex vivo data obtained from a 
laparoscopic training environment with porcine organs (challenge cohort), the final 
biomedical application (i.e. robotic kidney surgery) would be targeted on real patients 
with certain characteristics defined by inclusion criteria such as restrictions regarding 
gender or age (target cohort). 
 
a) Describe the target cohort, i.e. the subjects/objects from whom/which the data 
would be acquired in the final biomedical application. 
 
 
 
 
b) Describe the challenge cohort, i.e. the subject(s)/object(s) from whom/which the 
challenge data was acquired. 
 
 
 
 
Item 17: Imaging modality(ies) 
Specify the imaging technique(s) applied in the challenge. 
 
 
 
 
Item 18: Context information 
Provide additional information given along with the images. The information may 
correspond ... 
a) … directly to the image data (e.g. tumor volume). 
 
 
 
 
b) … to the patient in general (e.g. gender, medical history). 
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Item 19: Target entity(ies) 
a) Describe the data origin, i.e. the region(s)/part(s) of subject(s)/object(s) from 
whom/which the image data would be acquired in the final biomedical application 
(e.g. brain shown in computed tomography (CT) data, abdomen shown in 
laparoscopic video data, operating room shown in video data, thorax shown in 
fluoroscopy video). If necessary, differentiate between target and challenge cohort. 
 
 
 
 
b) Describe the algorithm target, i.e. the structure(s)/subject(s)/object(s)/component(s) 
that the participating algorithms have been designed to focus on  (e.g. tumor in the 
brain, tip of a medical instrument, nurse in an operating theater, catheter in a 
fluoroscopy scan). If necessary, differentiate between target and challenge cohort. 
 
 
 
 
Item 20: Assessment aim(s) 
Identify the property(ies) of the algorithms to be optimized to perform well in the 
challenge. If multiple properties are assessed, prioritize them (if appropriate). The 
properties should then be reflected in the metrics applied (parameter 26), and the 
priorities should be reflected in the ranking when combining multiple metrics that assess 
different properties. 
● Example 1: Find liver segmentation algorithm for CT images that processes CT images of a 
certain size in less than a minute on a certain hardware with an error that reflects inter-
rater variability of experts. 
● Example 2: Find lung tumor detection algorithm with high sensitivity and specificity for 
mammography images. 
Corresponding metrics are listed below (parameter 26). 
 
 
 
 
 
CHALLENGE DATA SETS 
 
Item 21: Data source(s) 
a) Specify the device(s) used to acquire the challenge data. This includes details on the 
device(s) used to acquire the imaging data (e.g. manufacturer) as well as information 
on additional devices used for performance assessment (e.g. tracking system used in a 
surgical setting). 
 
 
 
 
 
 
 Suppl 2: Structured description of a challenge design 
b) Describe relevant details on the imaging process/data acquisition for each 
acquisition device (e.g. image acquisition protocol(s)). 
 
 
 
 
c) Specify the center(s)/institute(s) in which the data was acquired and/or the data 
providing platform/source (e.g. previous challenge). If this information is not provided 
(e.g. for anonymization reasons), specify why. 
 
 
 
 
d) Describe relevant characteristics (e.g. level of expertise) of the subjects (e.g. 
surgeon)/objects (e.g. robot) involved in the data acquisition process (if any). 
 
 
 
 
Item 22: Training and test case characteristics 
a) State what is meant by one case in this challenge. A case encompasses all data that 
is processed to produce one result that is compared to the corresponding reference 
result (i.e. the desired algorithm output). 
Examples: 
● Training and test cases both represent a CT image of a human brain. Training cases have 
a weak annotation (tumor present or not and tumor volume (if any)) while the test cases 
are annotated with the tumor contour (if any). 
● A case refers to all information that is available for one particular patient in a specific 
study. This information always includes the image information as specified in data 
source(s) (parameter 21) and may include context information (parameter 18). Both 
training and test cases are annotated with survival (binary) 5 years after (first) image was 
taken. 
 
 
 
 
b) State the total number of training, validation and test cases. 
 
 
 
 
c) Explain why a total number of cases and the specific proportion of training, validation 
and test cases was chosen. 
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d) Mention further important characteristics of the training, validation and test cases 
(e.g. class distribution in classification tasks chosen according to real-world distribution 
vs. equal class distribution) and justify the choice. 
 
 
 
 
Item 23: Annotation characteristics 
a) Describe the method for determining the reference annotation, i.e. the desired 
algorithm output. Provide the information separately for the training, validation and test 
cases if necessary. Possible methods include manual image annotation, in silico ground 
truth generation and annotation by automatic methods. 
 
If human annotation was involved, state the number of annotators. 
 
 
 
 
b) Provide the instructions given to the annotators (if any) prior to the annotation. This 
may include description of a training phase with the software. Provide the information 
separately for the training, validation and test cases if necessary. Preferably, provide a 
link to the annotation protocol. 
 
 
 
 
c) Provide details on the subject(s)/algorithm(s) that annotated the cases (e.g. 
information on level of expertise such as number of years of professional experience, 
medically-trained or not). Provide the information separately for the training, validation 
and test cases if necessary. 
 
 
 
 
d) Describe the method(s) used to merge multiple annotations for one case (if any). 
Provide the information separately for the training, validation and test cases if 
necessary. 
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Item 24: Data pre-processing method(s) 
Describe the method(s) used for pre-processing the raw training data before it is 
provided to the participating teams. Provide the information separately for the training, 
validation and test cases if necessary. 
 
 
 
 
Item 25: Sources of error 
a) Describe the most relevant possible error sources related to the image annotation. If 
possible, estimate the magnitude (range) of these errors, using inter-and intra-annotator 
variability, for example. Provide the information separately for the training, validation 
and test cases, if necessary. 
 
 
 
 
b) In an analogous manner, describe and quantify other relevant sources of error. 
 
 
 
 
 
ASSESSMENT METHODS 
 
Item 26: Metric(s) 
a) Define the metric(s) to assess a property of an algorithm. These metrics should reflect 
the desired algorithm properties described in assessment aim(s) (parameter 20). State 
which metric(s) were used to compute the ranking(s) (if any). 
● Example 1: Dice Similarity Coefficient (DSC) and run-time 
● Example 2: Area under curve (AUC) 
 
 
 
 
b) Justify why the metric(s) was/were chosen, preferably with reference to the 
biomedical application. 
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Item 27: Ranking method(s) 
a) Describe the method used to compute a performance rank for all submitted 
algorithms based on the generated metric results on the test cases. Typically the text will 
describe how results obtained per case and metric are aggregated to arrive at a final 
score/ranking. 
 
 
 
 
b) Describe the method(s) used to manage submissions with missing results on test 
cases. 
 
 
 
 
c) Justify why the described ranking scheme(s) was/were used. 
 
 
 
 
Item 28: Statistical analyses 
a) Provide details for the statistical methods used in the scope of the challenge analysis. 
This may include 
● description of the missing data handling,  
● details about the assessment of variability of rankings,  
● description of any method used to assess whether the data met the assumptions, 
required for the particular statistical approach, or 
● indication of any software product that was used for all data analysis methods. 
 
 
 
 
b) Justify why the described statistical method(s) was/were used. 
 
 
 
 
Item 29: Further analyses 
Present further analyses to be performed (if applicable), e.g. related to  
● combining algorithms via ensembling, 
● inter-algorithm variability, 
● common problems/biases of the submitted methods, or 
● ranking variability. 
 
 
 
 
